Cargando…
A Systematic Review of the Sex and Gender Reporting in COVID-19 Clinical Trials
Sex and gender have implications for COVID-19 vaccine efficacy and adverse effects from the vaccine. As vaccination is one of the key responses to the COVID-19 pandemic, it is vital that sex and gender differences be acknowledged, measured, and analysed in clinical research. Here, we systematically...
Autores principales: | Heidari, Shirin, Palmer-Ross, Alice, Goodman, Tracey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622702/ https://www.ncbi.nlm.nih.gov/pubmed/34835253 http://dx.doi.org/10.3390/vaccines9111322 |
Ejemplares similares
-
Inadequate reporting of COVID-19 clinical studies: a renewed rationale for the Sex and Gender Equity in Research (SAGER) guidelines
por: Palmer-Ross, Alice, et al.
Publicado: (2021) -
Gender perspective in COVID-19. SESPAS Report 2022
por: Heidari, Shirin
Publicado: (2022) -
Resolving sex and gender bias in COVID-19 vaccines R&D and beyond
por: Vijayasingham, Lavanya, et al.
Publicado: (2022) -
Time for action: towards an intersectional gender approach to COVID-19 vaccine development and deployment that leaves no one behind
por: Heidari, Shirin, et al.
Publicado: (2021) -
Impact of COVID-19 on clinical trials and clinical research: A systematic review
por: Sathian, Brijesh, et al.
Publicado: (2020)